Sound Lateralization Test Distinguishes Unimpaired MS Patients from Healthy Controls.

IF 2.2 Q3 CLINICAL NEUROLOGY
Multiple Sclerosis International Pub Date : 2014-01-01 Epub Date: 2014-07-15 DOI:10.1155/2014/462043
Joshua H Bacon, Ilya Kister, Tamar E Bacon, Eliana Pasternak, Yael Strauchler, Joseph Herbert
{"title":"Sound Lateralization Test Distinguishes Unimpaired MS Patients from Healthy Controls.","authors":"Joshua H Bacon,&nbsp;Ilya Kister,&nbsp;Tamar E Bacon,&nbsp;Eliana Pasternak,&nbsp;Yael Strauchler,&nbsp;Joseph Herbert","doi":"10.1155/2014/462043","DOIUrl":null,"url":null,"abstract":"<p><p>There is an urgent need to develop a practical and reliable clinical measure of disease progression in early and mild MS. We hypothesized that a test of sound lateralization, which is exquisitely sensitive to transmission delays in auditory brainstem, could be more useful for detecting processing speed deficits in mildly impaired MS subjects than standard cognitive tasks. Objective. To develop a practical test of sound lateralization for the clinic and to compare performance of MS subjects with variable disability and healthy subjects on Sound Lateralization Test (SLT) and two speed-of-processing tasks. Design. 42 healthy controls and 90 subjects with clinically definite MS, divided into no, mild, and moderate disability strata, were administered the Symbol Digit Modalities Test (SDMT), and 3-second Paced Auditory Serial Addition Test (PASAT). Results. All of the tests showed an overall difference in performance between controls and the three MS groups, but only the SLT measured a significant difference between controls and the no disability group. Conclusion. SLT is rapidly applied, technically simple, and superior to standard processing speed tests for discriminating between healthy controls and nondisabled MS subjects. SLT should be investigated as an outcome measure in early-phase trials and for monitoring early disease progression in the clinic. </p>","PeriodicalId":46096,"journal":{"name":"Multiple Sclerosis International","volume":"2014 ","pages":"462043"},"PeriodicalIF":2.2000,"publicationDate":"2014-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2014/462043","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Multiple Sclerosis International","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1155/2014/462043","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2014/7/15 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 2

Abstract

There is an urgent need to develop a practical and reliable clinical measure of disease progression in early and mild MS. We hypothesized that a test of sound lateralization, which is exquisitely sensitive to transmission delays in auditory brainstem, could be more useful for detecting processing speed deficits in mildly impaired MS subjects than standard cognitive tasks. Objective. To develop a practical test of sound lateralization for the clinic and to compare performance of MS subjects with variable disability and healthy subjects on Sound Lateralization Test (SLT) and two speed-of-processing tasks. Design. 42 healthy controls and 90 subjects with clinically definite MS, divided into no, mild, and moderate disability strata, were administered the Symbol Digit Modalities Test (SDMT), and 3-second Paced Auditory Serial Addition Test (PASAT). Results. All of the tests showed an overall difference in performance between controls and the three MS groups, but only the SLT measured a significant difference between controls and the no disability group. Conclusion. SLT is rapidly applied, technically simple, and superior to standard processing speed tests for discriminating between healthy controls and nondisabled MS subjects. SLT should be investigated as an outcome measure in early-phase trials and for monitoring early disease progression in the clinic.

Abstract Image

Abstract Image

Abstract Image

声音侧化试验可区分未受损的多发性硬化症患者和健康对照。
迫切需要开发一种实用可靠的临床方法来衡量早期和轻度多发性硬化症的疾病进展。我们假设声音侧化测试对听觉脑干的传输延迟非常敏感,对于检测轻度受损多发性硬化症受试者的处理速度缺陷可能比标准认知任务更有用。目标。目的:为临床开发一种实用的声音偏侧化测试,并比较多发性硬化症可变残疾受试者和健康受试者在声音偏侧化测试(SLT)和两个快速处理任务上的表现。设计:将42名健康对照者和90名临床明确的MS患者分为无残疾、轻度残疾和中度残疾三组,分别进行符号数字模式测试(SDMT)和3秒节奏听觉序列加法测试(PASAT)。结果。所有的测试都显示了对照组和三个MS组之间的总体表现差异,但只有SLT测量了对照组和无残疾组之间的显著差异。结论。SLT应用迅速,技术简单,在区分健康对照和非残疾MS受试者方面优于标准处理速度测试。应将SLT作为早期临床试验的结果测量指标,并在临床中监测早期疾病进展。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Multiple Sclerosis International
Multiple Sclerosis International CLINICAL NEUROLOGY-
自引率
0.00%
发文量
6
审稿时长
15 weeks
期刊介绍: Multiple Sclerosis International is a peer-reviewed, Open Access journal that publishes original research articles, review articles, and clinical studies related to all aspects of multiple sclerosis, including clinical neurology, neuroimaging, neuropathology, therapeutics, genetics, neuroimmunology, biomarkers, psychology and neurorehabilitation.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信